TMZ 180 (Temozolomide 180 mg)
Pill with imprint TMZ 180 is Maroon / White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Accord Healthcare Inc.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TMZ 180
Temozolomide
- Imprint
- TMZ 180
- Strength
- 180 mg
- Color
- Maroon / White
- Size
- 9.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Accord Healthcare Inc.
- National Drug Code (NDC)
- 16729-0130
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A potato,
tartaric acid,
stearic acid,
ferric oxide red,
gelatin,
titanium dioxide,
ferric oxide yellow,
shellac,
potassium hydroxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about temozolomide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (8)
- Drug images
- Pricing & coupons
- En español
- Drug class: alkylating agents
Patient resources
- Drug Information
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
- Other brands
- Temodar
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.